Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Vaxcyte (PCVX) Shares Outstanding (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Shares Outstanding data on record, last reported at $144.3 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 11.92% to $144.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $144.3 million, a 11.92% increase, with the full-year FY2025 number at $131.1 million, up 4.94% from a year prior.
  • Shares Outstanding reached $144.3 million in Q1 2026 per PCVX's latest filing, up from $131.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PCVX hit a ceiling of $144.3 million in Q1 2026 and a floor of $56.5 million in Q1 2022.
  • A 5-year average of $103.1 million and a median of $108.8 million in 2024 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: surged 60.02% in 2023, then rose 4.5% in 2025.
  • Tracing PCVX's Shares Outstanding over 5 years: stood at $79.5 million in 2022, then increased by 20.0% to $95.4 million in 2023, then soared by 30.96% to $124.9 million in 2024, then rose by 4.94% to $131.1 million in 2025, then rose by 10.11% to $144.3 million in 2026.
  • Business Quant data shows Shares Outstanding for PCVX at $144.3 million in Q1 2026, $131.1 million in Q4 2025, and $130.0 million in Q3 2025.